Recognition List Number: 029 Publication Date: 08/20/2012
Part B: SUPPLEMENTARY INFORMATION
Recognition Number 7-197: CLSI M35-A2, Abbreviated Identification of Bacteria and Yeast; Approved Guideline - Second Edition. (InVitro Diagnostics)
Date of Standard: 2008. |
| Address of Standards Organization: |
| Clinical Laboratory Standards Institute (CLSI) |
| 950 West Valley Road |
| Suite 2500 |
| Wayne, PA 19087 |
| |
|
| CDRH Offices and Divisions Associated with Recognized Standards: |
| (1) | OFFICE OF DEVICE EVALUATION (ODE) |
|
| (2) | OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR) |
|
| (3) | OFFICE OF COMPLIANCE (OC) |
|
|
| Devices Affected: |
| Microorganism differentiation and identification device regulated under 21 CFR 866.2660 |
|
| Processes Affected: |
|
| Type of Standard: |
| Vertical, National |
| Extent of Recognition: |
|
| Related CFR Citations and Product Codes: |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §866.3310 |
Hepatitis A Test (Antibody And Igm Antibody) |
Class 2 |
LOL |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §866.2660 |
Discs, Strips And Reagents, Microorganism Differentiation |
Class 1 |
JTO |
| §866.2660 |
Gram Negative Identification Panel |
Class 1 |
LQM |
| §866.2660 |
Instrument For Auto Reader Of Overnight Microorganism Identification System |
Class 1 |
LRH |
| §866.2660 |
Kit, Anaerobic Identification |
Class 1 |
JSP |
| §866.2660 |
Kit, Screening, Yeast |
Class 1 |
JXC |
| |
|
| Relevant Guidance: |
1. Review Criteria for Assessment of Antimicrobial Susceptibility Discs
2. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry and FDA |
|
| FDA Technical Contacts: |
| Yvonne Shea |
| FDA/CDRH/OIVD |
| 10903 New Hampshire Avenue Building 66, Room 5510 |
| Silver Spring MD 20993 |
| 301/796-0576 |
| Email: yvonne.shea@fda.hhs.gov |
|
| Alexandra Wong |
| FDA/CDRH/OIVD |
| 10993 New Hampshire Avenue Building 66, Room 5502 |
| Silver Spring MD 20993 |
| 301/796-6210 |
| Email: alexandra.wong@fda.hhs.gov |
|
|